BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hartke J, Johnson M, Ghabril M. The diagnosis and treatment of hepatocellular carcinoma. Seminars in Diagnostic Pathology 2017;34:153-9. [DOI: 10.1053/j.semdp.2016.12.011] [Cited by in Crossref: 153] [Cited by in F6Publishing: 163] [Article Influence: 38.3] [Reference Citation Analysis]
Number Citing Articles
1 Meng YC, Lou XL, Yang LY, Li D, Hou YQ. Role of the autophagy-related marker LC3 expression in hepatocellular carcinoma: a meta-analysis. J Cancer Res Clin Oncol 2020;146:1103-13. [PMID: 32157437 DOI: 10.1007/s00432-020-03174-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
2 Ding J, Qin D, Zhang Y, Li Q, Li Y, Li J. SMAC mimetic birinapant inhibits hepatocellular carcinoma growth by activating the cIAP1/TRAF3 signaling pathway. Mol Med Rep 2020;21:1251-7. [PMID: 31922244 DOI: 10.3892/mmr.2020.10908] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
3 Guo X, Wang Y. LncRNA TMPO-AS1 promotes hepatocellular carcinoma cell proliferation, migration and invasion through sponging miR-329-3p to stimulate FOXK1-mediated AKT/mTOR signaling pathway. Cancer Med 2020;9:5235-46. [PMID: 32462698 DOI: 10.1002/cam4.3046] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 11.0] [Reference Citation Analysis]
4 Li Z, Xu J, Cui H, Song J, Chen J, Wei J. Bioinformatics analysis of key biomarkers and potential molecular mechanisms in hepatocellular carcinoma induced by hepatitis B virus. Medicine (Baltimore) 2020;99:e20302. [PMID: 32443377 DOI: 10.1097/MD.0000000000020302] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
5 Chen J, Yang J, Xu Q, Wang Z, Wu J, Pan L, Huang K, Wang C. Integrated bioinformatics analysis identified MTHFD1L as a potential biomarker and correlated with immune infiltrates in hepatocellular carcinoma. Biosci Rep 2021;41:BSR20202063. [PMID: 33605411 DOI: 10.1042/BSR20202063] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Liu HN, Wu H, Chen YJ, Tseng YJ, Bilegsaikhan E, Dong L, Shen XZ, Liu TT. Serum microRNA signatures and metabolomics have high diagnostic value in hepatocellular carcinoma. Oncotarget. 2017;8:108810-108824. [PMID: 29312570 DOI: 10.18632/oncotarget.22224] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
7 Pibiri M, Sulas P, Camboni T, Leoni VP, Simbula G. α-Lipoic acid induces Endoplasmic Reticulum stress-mediated apoptosis in hepatoma cells. Sci Rep 2020;10:7139. [PMID: 32345994 DOI: 10.1038/s41598-020-64004-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
8 Zhang XW, Li QH, Xu ZD, Dou JJ. STAT1-induced regulation of lncRNA ZFPM2-AS1 predicts poor prognosis and contributes to hepatocellular carcinoma progression via the miR-653/GOLM1 axis. Cell Death Dis 2021;12:31. [PMID: 33414427 DOI: 10.1038/s41419-020-03300-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Zhang Y, Ying X, Zhao Q, Ma J, Zhang D, He C, Han S. Identification of Protein Expression Changes in Hepatocellular Carcinoma through iTRAQ. Dis Markers 2020;2020:2632716. [PMID: 32076459 DOI: 10.1155/2020/2632716] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
10 Antoine AR, Joyce S, Joanna S, Christine K, Khoury Salem E, Philippe S. Gastrointestinal cancer characteristics in Lebanon. Arab J Gastroenterol 2021:S1687-1979(21)00065-4. [PMID: 34509388 DOI: 10.1016/j.ajg.2021.08.001] [Reference Citation Analysis]
11 Hou Y, Zhang G. Identification of immune-infiltrating cell-related biomarkers in hepatocellular carcinoma based on gene co-expression network analysis. Diagn Pathol 2021;16:57. [PMID: 34218795 DOI: 10.1186/s13000-021-01118-y] [Reference Citation Analysis]
12 Wang M, Wei C, Shi Z, Zhu J. Study on the diagnosis of small hepatocellular carcinoma caused by hepatitis B cirrhosis via multi-slice spiral CT and MRI. Oncol Lett. 2018;15:503-508. [PMID: 29375718 DOI: 10.3892/ol.2017.7313] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
13 Häfner SJ. High hopes and high honours for cancer immunotherapy. Biomed J 2019;42:293-8. [PMID: 31783989 DOI: 10.1016/j.bj.2019.10.001] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Liu Z, Li Z, Xu B, Yao H, Qi S, Tai J. Long Noncoding RNA PRR34-AS1 Aggravates the Progression of Hepatocellular Carcinoma by Adsorbing microRNA-498 and Thereby Upregulating FOXO3. Cancer Manag Res 2020;12:10749-62. [PMID: 33154667 DOI: 10.2147/CMAR.S263619] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
15 Dahdaleh FS, Naffouje SA, Sherman SK, Kamarajah SK, Salti GI. Tissue Diagnosis Is Associated With Worse Survival in Hepatocellular Carcinoma: A National Cancer Database Analysis. Am Surg 2021;:3134821991983. [PMID: 33830824 DOI: 10.1177/0003134821991983] [Reference Citation Analysis]
16 Jiang Z, Wang S, Hou J, Chi J, Wang S, Shao K, Liu W, Sun R, Han B. Effects of carboxymethyl chitosan oligosaccharide on regulating immunologic function and inhibiting tumor growth. Carbohydr Polym 2020;250:116994. [PMID: 33049904 DOI: 10.1016/j.carbpol.2020.116994] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
17 Ye L, Zhu L, Wang J, Li F. Inhibition of vitamin D analog eldecalcitol on hepatoma in vitro and in vivo. Open Med (Wars) 2020;15:663-71. [PMID: 33336024 DOI: 10.1515/med-2020-0137] [Reference Citation Analysis]
18 Zhu Q, Yu X, Zhou ZW, Luo M, Zhou C, He ZX, Chen Y, Zhou SF. A quantitative proteomic response of hepatocellular carcinoma Hep3B cells to danusertib, a pan-Aurora kinase inhibitor. J Cancer 2018;9:2061-71. [PMID: 29937924 DOI: 10.7150/jca.20822] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
19 Zhang Y, Zhang H, Wu S. LncRNA-CCDC144NL-AS1 Promotes the Development of Hepatocellular Carcinoma by Inducing WDR5 Expression via Sponging miR-940. J Hepatocell Carcinoma 2021;8:333-48. [PMID: 33977095 DOI: 10.2147/JHC.S306484] [Reference Citation Analysis]
20 Li L, Xie R, Lu G. Identification of m6A methyltransferase-related lncRNA signature for predicting immunotherapy and prognosis in patients with hepatocellular carcinoma. Biosci Rep 2021;41:BSR20210760. [PMID: 34027555 DOI: 10.1042/BSR20210760] [Reference Citation Analysis]
21 Chen W, Tang D, Ou M, Dai Y. Mining Prognostic Biomarkers of Hepatocellular Carcinoma Based on Immune-Associated Genes. DNA Cell Biol 2020;39:499-512. [PMID: 32069130 DOI: 10.1089/dna.2019.5099] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
22 Chen MY, Yadav VK, Chu YC, Ong JR, Huang TY, Lee KF, Lee KH, Yeh CT, Lee WH. Hydroxychloroquine (HCQ) Modulates Autophagy and Oxidative DNA Damage Stress in Hepatocellular Carcinoma to Overcome Sorafenib Resistance via TLR9/SOD1/hsa-miR-30a-5p/Beclin-1 Axis. Cancers (Basel) 2021;13:3227. [PMID: 34203465 DOI: 10.3390/cancers13133227] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
23 Li Y, Ding X, Xiu S, Du G, Liu Y. LncRNA NEAT1 Promotes Proliferation, Migration And Invasion Via Regulating miR-296-5p/CNN2 Axis In Hepatocellular Carcinoma Cells. Onco Targets Ther 2019;12:9887-97. [PMID: 31819486 DOI: 10.2147/OTT.S228917] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
24 Chi X, Jiang Y, Chen Y, Lv L, Chen J, Yang F, Zhang X, Pan F, Cai Q. microR-505/heterogeneous nuclear ribonucleoprotein M inhibits hepatocellular carcinoma cell proliferation and induces cell apoptosis through the Wnt/β-catenin signaling pathway. Biomark Med 2020;14:981-96. [PMID: 32940078 DOI: 10.2217/bmm-2019-0511] [Reference Citation Analysis]
25 Wang X, Tan Y, Zhang Y, Xu Z, Xu B, Lei H, Ding C, Cheng S, Wang X, Wei P, Wang Z, Mao Q, Ai C, Hua Q. The novel glycyrrhetinic acid–tetramethylpyrazine conjugate TOGA induces anti-hepatocarcinogenesis by inhibiting the effects of tumor-associated macrophages on tumor cells. Pharmacological Research 2020;161:105233. [DOI: 10.1016/j.phrs.2020.105233] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
26 Lorenc T, Chrzanowski J, Olejarz W. Current Perspectives on Clinical Use of Exosomes as a Personalized Contrast Media and Theranostics. Cancers (Basel) 2020;12:E3386. [PMID: 33207614 DOI: 10.3390/cancers12113386] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
27 Sun Y, Zhou Q, Li J, Zhao C, Yu Z, Zhu Q. LncRNA RP11-422N16.3 Inhibits Cell Proliferation and EMT, and Induces Apoptosis in Hepatocellular Carcinoma Cells by Sponging miR-23b-3p. Onco Targets Ther 2019;12:10943-61. [PMID: 31849497 DOI: 10.2147/OTT.S232243] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
28 Lin Y, Zheng ZH, Wang JX, Zhao Z, Peng TY. Tumor Cell-Derived Exosomal Circ-0072088 Suppresses Migration and Invasion of Hepatic Carcinoma Cells Through Regulating MMP-16. Front Cell Dev Biol 2021;9:726323. [PMID: 34568335 DOI: 10.3389/fcell.2021.726323] [Reference Citation Analysis]
29 Peña-Asensio J, Calvo H, Torralba M, Miquel J, Sanz-de-Villalobos E, Larrubia JR. Anti-PD-1/PD-L1 Based Combination Immunotherapy to Boost Antigen-Specific CD8+ T Cell Response in Hepatocellular Carcinoma. Cancers (Basel) 2021;13:1922. [PMID: 33923463 DOI: 10.3390/cancers13081922] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
30 Lu H, Zheng C, Liang B, Xiong B. Mechanism and risk factors of nausea and vomiting after TACE: a retrospective analysis. BMC Cancer 2021;21:513. [PMID: 33962555 DOI: 10.1186/s12885-021-08253-1] [Reference Citation Analysis]
31 Wang T, Li P, Wan T, Tu B, Li J, Huang F. TIGIT/PVR and LncRNA ANRIL dual-targetable PAMAM polymeric nanoparticles efficiently inhibited the hepatoma carcinoma by combination of immunotherapy and gene therapy. J Drug Target 2021;29:783-91. [PMID: 33480288 DOI: 10.1080/1061186X.2021.1879088] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
32 Lu H, Zheng C, Liang B, Xiong B. Efficacy and safety analysis of dexamethasone-lipiodol emulsion in prevention of post-embolization syndrome after TACE: a retrospective analysis. BMC Gastroenterol 2021;21:256. [PMID: 34116638 DOI: 10.1186/s12876-021-01839-w] [Reference Citation Analysis]
33 Sun Q, Zhang X, Tan Z, Gu H, Ding S, Ji Y. Bone marrow mesenchymal stem cells-secreted exosomal microRNA-205-5p exerts inhibitory effect on the progression of liver cancer through regulating CDKL3. Pathol Res Pract 2021;225:153549. [PMID: 34329837 DOI: 10.1016/j.prp.2021.153549] [Reference Citation Analysis]
34 He Y, Dang Q, Li J, Zhang Q, Yu X, Xue M, Guo W. Prediction of hepatocellular carcinoma prognosis based on expression of an immune-related gene set. Aging (Albany NY) 2020;12:965-77. [PMID: 31929113 DOI: 10.18632/aging.102669] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 18.0] [Reference Citation Analysis]
35 Xie A, Xia F, Pei J, Sun X, Song Z. Advanced hepatocellular carcinoma treated by radiofrequency ablation combined with oncolytic virus and anti-PD-1 antibody therapy: a case report and literature review. J Int Med Res 2021;49:3000605211044596. [PMID: 34559020 DOI: 10.1177/03000605211044596] [Reference Citation Analysis]
36 Wang Y, Zhang B, Huang Y, Yao W, Tao F, Chen Y. Novel Bradykinin Receptor Inhibitors Inhibit Proliferation and Promote the Apoptosis of Hepatocellular Carcinoma Cells by Inhibiting the ERK Pathway. Molecules 2021;26:3915. [PMID: 34206871 DOI: 10.3390/molecules26133915] [Reference Citation Analysis]
37 Su Q, Wang H. Long non-coding RNA 01559 mediates the malignant phenotypes of hepatocellular carcinoma cells through targeting miR-511. Clin Res Hepatol Gastroenterol 2021;45:101648. [PMID: 33588099 DOI: 10.1016/j.clinre.2021.101648] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
38 Shyu S, Ali SZ. Significance of hepatocyte atypia in liver fine needle aspiration. Diagn Cytopathol 2021. [PMID: 34459153 DOI: 10.1002/dc.24851] [Reference Citation Analysis]
39 Tong X, Wang Q, Wu D, Bao L, Yin T, Chen H. MEK inhibition by cobimetinib suppresses hepatocellular carcinoma and angiogenesis in vitro and in vivo. Biochem Biophys Res Commun 2020;523:147-52. [PMID: 31836141 DOI: 10.1016/j.bbrc.2019.12.032] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
40 Sun Z, Zhao L, Wang S, Wang H. Knockdown of long non-coding RNA LINC01006 represses the development of hepatocellular carcinoma by modulating the miR-194-5p/CADM1 axis. Ann Hepatol 2021;:100571. [PMID: 34718169 DOI: 10.1016/j.aohep.2021.100571] [Reference Citation Analysis]
41 Lei Z, Tang X, Si A, Yang P, Wang L, Luo T, Guo G, Zhang Q, Cheng Z. microRNA-454 promotes liver tumor-initiating cell expansion by regulating SOCS6. Exp Cell Res 2020;390:111955. [PMID: 32165166 DOI: 10.1016/j.yexcr.2020.111955] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
42 Wang H, Wang R, Huang D, Li S, Gao B, Kang Z, Tang B, Xie J, Yan F, Liang R, Li H, Yan J. Homoharringtonine Exerts Anti-tumor Effects in Hepatocellular Carcinoma Through Activation of the Hippo Pathway. Front Pharmacol 2021;12:592071. [PMID: 33716735 DOI: 10.3389/fphar.2021.592071] [Reference Citation Analysis]
43 Korean Liver Cancer Association., National Cancer Center. 2018 Korean Liver Cancer Association-National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma. Gut Liver 2019;13:227-99. [PMID: 31060120 DOI: 10.5009/gnl19024] [Cited by in Crossref: 90] [Cited by in F6Publishing: 88] [Article Influence: 90.0] [Reference Citation Analysis]
44 Tong Y, Wang M, Huang H, Zhang J, Huang Y, Chen Y, Pan H. Inhibitory effects of genistein in combination with gefitinib on the hepatocellular carcinoma Hep3B cell line. Exp Ther Med 2019;18:3793-800. [PMID: 31611933 DOI: 10.3892/etm.2019.8027] [Reference Citation Analysis]
45 Shi Y, Zhang L, Bao Y, Wu P, Zhang X. Association of TNIP1 polymorphisms with hepatocellular carcinoma in a Northwest Chinese Han population. Medicine (Baltimore) 2021;100:e24843. [PMID: 33761643 DOI: 10.1097/MD.0000000000024843] [Reference Citation Analysis]
46 Bai Y, Zheng Z, Du M, Yao H, Liu Y, Suo J. Bloodstream Infection and Its Clinical Characteristics and Relevant Factors Associated with Interventional Therapy in a Large Tertiary Hospital: A Six Years Surveillance Study. Biomed Res Int 2019;2019:8190475. [PMID: 31781645 DOI: 10.1155/2019/8190475] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
47 Chen J, Chen C, Lin Y, Su Y, Yu X, Jiang Y, Chen Z, Ke S, Lin S, Chen L, Zhang Z, Zhang T. Downregulation of SUMO2 inhibits hepatocellular carcinoma cell proliferation, migration and invasion. FEBS Open Bio 2021;11:1771-84. [PMID: 33989451 DOI: 10.1002/2211-5463.13173] [Reference Citation Analysis]
48 Huang Z, Xia H, Liu S, Zhao X, He R, Wang Z, Shi W, Chen W, Kang P, Su Z, Cui Y, Yam JWP, Xu Y. The Mechanism and Clinical Significance of Circular RNAs in Hepatocellular Carcinoma. Front Oncol 2021;11:714665. [PMID: 34540684 DOI: 10.3389/fonc.2021.714665] [Reference Citation Analysis]
49 Chao X, Zhang W, Wu J, Feng X, Shi H, Zhao L, Shen H, Jiang C. Downregulation of LHPP Expression Associated with AFP Acts as a Good Prognostic Factor in Human Hepatocellular Carcinoma. Biomed Res Int 2021;2021:1971048. [PMID: 34485511 DOI: 10.1155/2021/1971048] [Reference Citation Analysis]
50 He Y, Tao W, Shang C, Qi C, Ji D, Lu W, Chen G. Xeroderma Pigmentosum group D suppresses proliferation and promotes apoptosis of HepG2 cells by downregulating ERG expression via the PPARγ pathway. Int J Exp Pathol 2021;102:157-62. [PMID: 33993564 DOI: 10.1111/iep.12396] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
51 Liu X, Dong S, Dong M, Li Y, Sun Z, Zhang X, Wang Y, Teng L, Wang D. Transferrin-conjugated liposomes loaded with carnosic acid inhibit liver cancer growth by inducing mitochondria-mediated apoptosis. Int J Pharm 2021;607:121034. [PMID: 34425193 DOI: 10.1016/j.ijpharm.2021.121034] [Reference Citation Analysis]
52 Kim KH, Oh HH, Son DJ, Hong JY, Jeong YH, Jung JS, Yu HM, Myung DS, Cho SB, Lee WS, Kim JW, Joo YE. Scapular metastasis of hepatocellular carcinoma presenting as acute bleeding and hematoma: A case report of safe and effective treatment. Medicine (Baltimore) 2017;96:e8736. [PMID: 29145320 DOI: 10.1097/MD.0000000000008736] [Reference Citation Analysis]
53 Dong Y, Wang Q, Sun J, Liu H, Wang H. Long non-coding RNA TPTEP1 exerts inhibitory effects on hepatocellular carcinoma by impairing microRNA-454-3p-mediated DLG5 downregulation. Dig Liver Dis 2021:S1590-8658(21)00199-7. [PMID: 34238665 DOI: 10.1016/j.dld.2021.04.014] [Reference Citation Analysis]
54 Min J, Jin D, Zhang F, Kang Y, Qi Y, Du P. DLG1-AS1 is activated by MYC and drives the proliferation and migration of hepatocellular carcinoma cells through miR-497-5p/SSRP1 axis. Cancer Cell Int 2021;21:16. [PMID: 33407499 DOI: 10.1186/s12935-020-01667-0] [Reference Citation Analysis]
55 Sheng QJ, Tian WY, Dou XG, Zhang C, Li YW, Han C, Fan YX, Lai PP, Ding Y. Programmed death 1, ligand 1 and 2 correlated genes and their association with mutation, immune infiltration and clinical outcomes of hepatocellular carcinoma. World J Gastrointest Oncol 2020; 12(11): 1255-1271 [PMID: 33250959 DOI: 10.4251/wjgo.v12.i11.1255] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
56 Liu J, Chen Z, Li W. Machine Learning for Building Immune Genetic Model in Hepatocellular Carcinoma Patients. J Oncol 2021;2021:6676537. [PMID: 33790969 DOI: 10.1155/2021/6676537] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
57 Zhang J, Wang X, Li G, He J, Lu Z, Yang Y, Jiang Y, Jiang L, Li F, Liu J. COPB2: A Novel Prognostic Biomarker That Affects Progression of HCC. Biomed Res Int 2021;2021:6648078. [PMID: 33824874 DOI: 10.1155/2021/6648078] [Reference Citation Analysis]
58 Jiang Z, Zhang C, Liu X, Ma X, Bian X, Xiao X, Gao R, Sun Y, Wu W, Zhao P. Dexamethasone inhibits stemness maintenance and enhances chemosensitivity of hepatocellular carcinoma stem cells by inducing deSUMOylation of HIF‑1α and Oct4. Int J Oncol 2020;57:780-90. [PMID: 32705164 DOI: 10.3892/ijo.2020.5097] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
59 Le J, Fu Y, Han Q, Ma Y, Ji H, Wei X, Chen Y, Sun Y, Gao Y, Wu H. Transcriptome Analysis of the Inhibitory Effect of Sennoside A on the Metastasis of Hepatocellular Carcinoma Cells. Front Pharmacol 2020;11:566099. [PMID: 33708105 DOI: 10.3389/fphar.2020.566099] [Reference Citation Analysis]
60 Kovac JD, Ivanovic A, Milovanovic T, Micev M, Alessandrino F, Gore RM. An overview of hepatocellular carcinoma with atypical enhancement pattern: spectrum of magnetic resonance imaging findings with pathologic correlation. Radiol Oncol 2021;55:130-43. [PMID: 33544992 DOI: 10.2478/raon-2021-0004] [Reference Citation Analysis]
61 Cheng J, Li Y, Wang X, Dong Z, Chen Y, Zhang R, Huang J, Jin X, Yao J, Ge A, Song L, Lu Y, Zeng Z. Response Stratification in the First-Line Combined Immunotherapy of Hepatocellular Carcinoma at Genomic, Transcriptional and Immune Repertoire Levels. J Hepatocell Carcinoma 2021;8:1281-95. [PMID: 34737983 DOI: 10.2147/JHC.S326356] [Reference Citation Analysis]
62 Meng M, Wu YC. Combination of AAV-CCL19 and GPC3 CAR-T Cells in the Treatment of Hepatocellular Carcinoma. J Immunol Res 2021;2021:1782728. [PMID: 34527749 DOI: 10.1155/2021/1782728] [Reference Citation Analysis]
63 Xu D, Wang Y, Wu J, Zhang Z, Chen J, Xie M, Tang R, Cheng C, Chen L, Lin S, Luo X, Zheng J. MTIF2 impairs 5 fluorouracil-mediated immunogenic cell death in hepatocellular carcinoma in vivo: Molecular mechanisms and therapeutic significance. Pharmacol Res 2021;163:105265. [PMID: 33129983 DOI: 10.1016/j.phrs.2020.105265] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
64 Ma X, Ding Y, Zeng L. The diagnostic and prognostic value of H2AFY in hepatocellular carcinoma. BMC Cancer 2021;21:418. [PMID: 33858382 DOI: 10.1186/s12885-021-08161-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
65 Li Z, Mou L, Gao H, Zeng Y, Tang X, Deng X, Pu Z, Ni Y, Zhan Y. Diagnostic accuracy of serum dickkopf-1 protein in diagnosis hepatocellular carcinoma: An updated meta-analysis. Medicine (Baltimore) 2019;98:e16725. [PMID: 31393380 DOI: 10.1097/MD.0000000000016725] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
66 Wu M, Mei F, Liu W, Jiang J. Comprehensive characterization of tumor infiltrating natural killer cells and clinical significance in hepatocellular carcinoma based on gene expression profiles. Biomed Pharmacother. 2020;121:109637. [PMID: 31810126 DOI: 10.1016/j.biopha.2019.109637] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
67 Chen Z, Zou Y, Zhang Y, Chen Z, Wu F, Shi N, Jin H. A novel prognostic signature based on four glycolysis-related genes predicts survival and clinical risk of hepatocellular carcinoma. J Clin Lab Anal 2021;35:e24005. [PMID: 34523732 DOI: 10.1002/jcla.24005] [Reference Citation Analysis]
68 Zhang Y, Wang H, Li C, Gao L, Zheng Y, Chang W, Lu C, Zhao X. CircSMYD4 regulates proliferation, migration and apoptosis of hepatocellular carcinoma cells by sponging miR-584-5p. Cancer Cell Int 2020;20:556. [PMID: 33292243 DOI: 10.1186/s12935-020-01648-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
69 Wang L, Wang X, Wang X. The effectiveness of enteral nutrition for patients with primary liver cancer: A randomized controlled study protocol. Medicine (Baltimore) 2021;100:e23973. [PMID: 33545982 DOI: 10.1097/MD.0000000000023973] [Reference Citation Analysis]
70 Lin H, Zhou W, Huang Y, Ren M, Xu F, Wang H. Systemic hypoxia potentiates anti-tumor effects of metformin in hepatocellular carcinoma in mice. Acta Biochim Biophys Sin (Shanghai) 2020;52:421-9. [PMID: 32250393 DOI: 10.1093/abbs/gmaa010] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
71 Ding H, Hu H, Tian F, Liang H. A dual immune signature of CD8+ T cells and MMP9 improves the survival of patients with hepatocellular carcinoma. Biosci Rep 2021;41:BSR20204219. [PMID: 33656546 DOI: 10.1042/BSR20204219] [Reference Citation Analysis]
72 Li F, Sun X, Liu Q, Liu X, Zhang J. Long Noncoding RNA MIR100HG Knockdown Attenuates Hepatocellular Carcinoma Progression by Regulating MicroRNA-146b-5p/Chromobox 6. Gastroenterol Res Pract 2021;2021:6832518. [PMID: 34381502 DOI: 10.1155/2021/6832518] [Reference Citation Analysis]
73 Li J, Zhou J, Kai S, Wang C, Wang D, Jiang J. Network-Based Coexpression Analysis Identifies Functional and Prognostic Long Noncoding RNAs in Hepatocellular Carcinoma. Biomed Res Int 2020;2020:1371632. [PMID: 33083449 DOI: 10.1155/2020/1371632] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
74 Liu B, Yang G, Wang X, Liu J, Lu Z, Wang Q, Xu B, Liu Z, Li J. CircBACH1 (hsa_circ_0061395) promotes hepatocellular carcinoma growth by regulating p27 repression via HuR. J Cell Physiol 2020;235:6929-41. [PMID: 32003018 DOI: 10.1002/jcp.29589] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 19.0] [Reference Citation Analysis]
75 Gao Y, Gu J, Wang Y, Fu D, Zhang W, Zheng G, Wang X. Hepatitis B virus X protein boosts hepatocellular carcinoma progression by downregulating microRNA-137. Pathol Res Pract 2020;216:152981. [PMID: 32527447 DOI: 10.1016/j.prp.2020.152981] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
76 Mi N, Cao J, Zhang J, Fu W, Huang C, Gao L, Yue P, Bai B, Lin Y, Meng W, Li X. Identification of hub genes involved in the occurrence and development of hepatocellular carcinoma via bioinformatics analysis. Oncol Lett 2020;20:1695-708. [PMID: 32724412 DOI: 10.3892/ol.2020.11752] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
77 Fei ZY, Wang WS, Li SF, Zi JJ, Yang L, Liu T, Ao S, Liu QQ, Cui QH, Yu M, Xiong W. High expression of the TEFM gene predicts poor prognosis in hepatocellular carcinoma. J Gastrointest Oncol 2020;11:1291-304. [PMID: 33457002 DOI: 10.21037/jgo-20-120] [Reference Citation Analysis]
78 Chao Y, Zhou D. lncRNA-D16366 Is a Potential Biomarker for Diagnosis and Prognosis of Hepatocellular Carcinoma. Med Sci Monit 2019;25:6581-6. [PMID: 31475695 DOI: 10.12659/MSM.915100] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 12.5] [Reference Citation Analysis]
79 He S, Guo Z, Kang Q, Wang X, Han X. Circular RNA hsa_circ_0000517 modulates hepatocellular carcinoma advancement via the miR-326/SMAD6 axis. Cancer Cell Int 2020;20:360. [PMID: 32774154 DOI: 10.1186/s12935-020-01447-w] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
80 Xu L, Zheng Q. A Novel Expression Signature from the Perspective of Mesenchymal-Epithelial Transition for Hepatocellular Carcinoma with Regard to Prognosis, Clinicopathological Features, Immune Cell Infiltration, Chemotherapeutic Efficacy, and Immunosuppressive Molecules. J Oncol 2021;2021:5033416. [PMID: 34367283 DOI: 10.1155/2021/5033416] [Reference Citation Analysis]
81 Chen X, Ding L, Kong D, Zhao X, Liao L, Zhang Y, Li F, Liu R. FXYD6 overexpression in HBV-related hepatocellular carcinoma with cirrhosis. Open Life Sci 2020;15:259-66. [PMID: 33817214 DOI: 10.1515/biol-2020-0027] [Reference Citation Analysis]
82 Lou W, Chen J, Ding B, Fan W. XIAP, commonly targeted by tumor suppressive miR-3607-5p and miR-3607-3p, promotes proliferation and inhibits apoptosis in hepatocellular carcinoma. Genomics 2021;113:933-45. [PMID: 33588071 DOI: 10.1016/j.ygeno.2021.02.003] [Reference Citation Analysis]
83 Pu J, Wang J, Li W, Lu Y, Wu X, Long X, Luo C, Wei H. hsa_circ_0000092 promotes hepatocellular carcinoma progression through up-regulating HN1 expression by binding to microRNA-338-3p. J Cell Mol Med 2020. [PMID: 32077624 DOI: 10.1111/jcmm.15010] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 17.0] [Reference Citation Analysis]
84 Parama D, Boruah M, Yachna K, Rana V, Banik K, Harsha C, Thakur KK, Dutta U, Arya A, Mao X, Ahn KS, Kunnumakkara AB. Diosgenin, a steroidal saponin, and its analogs: Effective therapies against different chronic diseases. Life Sci 2020;260:118182. [PMID: 32781063 DOI: 10.1016/j.lfs.2020.118182] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 18.0] [Reference Citation Analysis]
85 Liu W, Yin C, Liu Y. Circular RNA circ_0091579 Promotes Hepatocellular Carcinoma Proliferation, Migration, Invasion, and Glycolysis Through miR-490-5p/CASC3 Axis. Cancer Biother Radiopharm 2020. [PMID: 32673066 DOI: 10.1089/cbr.2019.3472] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
86 Huang J, Gu Z, Chen W, Xu Y, Chen M. Knockdown of ubiquitin‐specific peptidase 13 inhibits cell growth of hepatocellular carcinoma by reducing c‐Myc expression. The Kaohsiung Journal of Medical Sciences 2020;36:615-21. [DOI: 10.1002/kjm2.12209] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
87 Wang SY, Yin L, Wang C, Ma MP. Atypical magnetic resonance imaging features and differential diagnosis of hepatocellular carcinoma. J Int Med Res 2020;48:300060520943415. [PMID: 33081554 DOI: 10.1177/0300060520943415] [Reference Citation Analysis]
88 Fleming BD, Ho M. Development of Glypican-3 Targeting Immunotoxins for the Treatment of Liver Cancer: An Update. Biomolecules 2020;10:E934. [PMID: 32575752 DOI: 10.3390/biom10060934] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
89 Jiang Z, Shen L, Wang S, Wu S, Hu Y, Guo J, Fu L. Hsa_circ_0028502 and hsa_circ_0076251 are potential novel biomarkers for hepatocellular carcinoma. Cancer Med 2019;8:7278-87. [PMID: 31595711 DOI: 10.1002/cam4.2584] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
90 Hu B, An HM, Yan X, Zheng JL, Huang XW, Li M. Traditional Chinese medicine formulation Yanggan Jiedu Sanjie inhibits TGF-β1-induced epithelial-mesenchymal transition and metastatic potential in human hepatocarcinoma Bel-7402 cells. BMC Complement Altern Med 2019;19:67. [PMID: 30876428 DOI: 10.1186/s12906-019-2477-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
91 Lin X, Xiang X, Feng B, Zhou H, Wang T, Chu X, Wang R. Targeting Long Non-Coding RNAs in Hepatocellular Carcinoma: Progress and Prospects. Front Oncol 2021;11:670838. [PMID: 34249710 DOI: 10.3389/fonc.2021.670838] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
92 Lin Y, Liang R, Ye J, Li Q, Liu Z, Gao X, Piao X, Mai R, Zou D, Ge L. A twenty gene-based gene set variation score reflects the pathological progression from cirrhosis to hepatocellular carcinoma. Aging (Albany NY) 2019;11:11157-69. [PMID: 31811111 DOI: 10.18632/aging.102518] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
93 Liu Y, Zou H, Xie Q, Zou L, Kong R, Mao B. Ribonucleic acid-binding protein CPSF6 promotes glycolysis and suppresses apoptosis in hepatocellular carcinoma cells by inhibiting the BTG2 expression. Biomed Eng Online 2021;20:67. [PMID: 34217312 DOI: 10.1186/s12938-021-00903-6] [Reference Citation Analysis]
94 Chen C, Su N, Li G, Shen Y, Duan X. Long non-coding RNA TMCC1-AS1 predicts poor prognosis and accelerates epithelial-mesenchymal transition in liver cancer. Oncol Lett 2021;22:773. [PMID: 34589152 DOI: 10.3892/ol.2021.13034] [Reference Citation Analysis]
95 Liang C, Dong Z, Cai X, Shen J, Xu Y, Zhang M, Li H, Yu W, Chen W. Hypoxia induces sorafenib resistance mediated by autophagy via activating FOXO3a in hepatocellular carcinoma. Cell Death Dis 2020;11:1017. [PMID: 33250518 DOI: 10.1038/s41419-020-03233-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
96 Nakano M, Kuromatsu R, Niizeki T, Okamura S, Iwamoto H, Shimose S, Shirono T, Noda Y, Kamachi N, Koga H, Torimura T; Kurume Liver Cancer Study Group of Japan. Immunological inflammatory biomarkers as prognostic predictors for advanced hepatocellular carcinoma. ESMO Open 2021;6:100020. [PMID: 33399083 DOI: 10.1016/j.esmoop.2020.100020] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
97 Liu Q, Zhou C, Zhang B. Upregulation of musashi1 increases malignancy of hepatocellular carcinoma via the Wnt/β-catenin signaling pathway and predicts a poor prognosis. BMC Gastroenterol 2019;19:230. [PMID: 31888604 DOI: 10.1186/s12876-019-1150-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
98 Zhang X, Zhang X, Li X, Bao H, Li G, Li N, Li H, Dou J. Connection Between CDC20 Expression and Hepatocellular Carcinoma Prognosis. Med Sci Monit 2021;27:e926760. [PMID: 33788826 DOI: 10.12659/MSM.926760] [Reference Citation Analysis]
99 Jiang Z, Wang S, Jin J, Ying S, Chen Z, Zhu D, Xiao B, Hu Y, Qian Y, Cai T, Fu L. The clinical significance of serum chitinase 3-like 1 in hepatitis B-related chronic liver diseases. J Clin Lab Anal 2020;34:e23200. [PMID: 31916309 DOI: 10.1002/jcla.23200] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
100 Oh SH, Swiderska-Syn M, Jewell ML, Premont RT, Diehl AM. Liver regeneration requires Yap1-TGFβ-dependent epithelial-mesenchymal transition in hepatocytes. J Hepatol 2018;69:359-67. [PMID: 29758331 DOI: 10.1016/j.jhep.2018.05.008] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 13.3] [Reference Citation Analysis]
101 Tu K, Li J, Mo H, Xian Y, Xu Q, Xiao X. Identification and validation of redox-immune based prognostic signature for hepatocellular carcinoma. Int J Med Sci 2021;18:2030-41. [PMID: 33850474 DOI: 10.7150/ijms.56289] [Reference Citation Analysis]
102 Zhao Y, Wang Z, Zhang W, Zhang L. MicroRNAs play an essential role in autophagy regulation in various disease phenotypes. Biofactors. 2019;45:844-856. [PMID: 31418958 DOI: 10.1002/biof.1555] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 9.5] [Reference Citation Analysis]
103 Bao H, Muge Q. Anticancer effect of myristicin on hepatic carcinoma and related molecular mechanism. Pharm Biol 2021;59:1126-32. [PMID: 34410900 DOI: 10.1080/13880209.2021.1961825] [Reference Citation Analysis]
104 Chen Q, Li F, Gao Y, Xu G, Liang L, Xu J. Identification of Energy Metabolism Genes for the Prediction of Survival in Hepatocellular Carcinoma. Front Oncol 2020;10:1210. [PMID: 32903581 DOI: 10.3389/fonc.2020.01210] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
105 Zhang Y, Jiang X, Li X, Găman MA, Kord-Varkaneh H, Rahmani J, Salehi-Sahlabadi A, Day AS, Xu Y. Serum Vitamin D Levels and Risk of Liver Cancer: A Systematic Review and Dose-Response Meta-Analysis of Cohort Studies. Nutr Cancer 2021;73:1-9. [PMID: 32705896 DOI: 10.1080/01635581.2020.1797127] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
106 Ren Q, Xiao X, Leng X, Zhang Q, Zhou X, Ren Z, Xiao H. MicroRNA-361-5p induces hepatocellular carcinoma cell apoptosis and enhances drug sensitivity by targeting MAP3K9. Exp Ther Med 2021;21:574. [PMID: 33850546 DOI: 10.3892/etm.2021.10006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
107 Jin S, Tan S, Peng W, Jiang Y, Luo C. Radiofrequency ablation versus laparoscopic hepatectomy for treatment of hepatocellular carcinoma: a systematic review and meta-analysis. World J Surg Oncol 2020;18:199. [PMID: 32787883 DOI: 10.1186/s12957-020-01966-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
108 Ye Y, Yu F, Li Z, Xie Y, Yu X. RNA binding protein serine/arginine splicing factor 1 promotes the proliferation, migration and invasion of hepatocellular carcinoma by interacting with RecQ protein-like 4 mRNA. Bioengineered 2021;12:6144-54. [PMID: 34486474 DOI: 10.1080/21655979.2021.1972785] [Reference Citation Analysis]
109 Ding H, Liu J, Wang C, Su Y. NONO promotes hepatocellular carcinoma progression by enhancing fatty acids biosynthesis through interacting with ACLY mRNA. Cancer Cell Int 2020;20:425. [PMID: 32884448 DOI: 10.1186/s12935-020-01520-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
110 Liu L, Shui Y, Yu Q, Guo Y, Zhang L, Zhou X, Yu R, Lou J, Wei S, Wei Q. Narrow-Margin Hepatectomy Resulted in Higher Recurrence and Lower Overall Survival for R0 Resection Hepatocellular Carcinoma. Front Oncol 2020;10:610636. [PMID: 33552983 DOI: 10.3389/fonc.2020.610636] [Reference Citation Analysis]
111 Zhang ZM, Tan JX, Wang F, Dao FY, Zhang ZY, Lin H. Early Diagnosis of Hepatocellular Carcinoma Using Machine Learning Method. Front Bioeng Biotechnol 2020;8:254. [PMID: 32292778 DOI: 10.3389/fbioe.2020.00254] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 19.0] [Reference Citation Analysis]
112 Zhang K, Liu H, Yu M, Zhao H, Yang N, Bi X, Sun L, Lin R, Lü G. Upregulated LINC01667 Expression Is Correlated With Poor Prognosis in Hepatocellular Carcinoma. Front Oncol 2021;11:650173. [PMID: 34458133 DOI: 10.3389/fonc.2021.650173] [Reference Citation Analysis]
113 Rashed WM, Kandeil MAM, Mahmoud MO, Ezzat S. Hepatocellular Carcinoma (HCC) in Egypt: A comprehensive overview. J Egypt Natl Canc Inst 2020;32:5. [PMID: 32372179 DOI: 10.1186/s43046-020-0016-x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 26.0] [Reference Citation Analysis]
114 He D, Liao S, Cai L, Huang W, Xie X, You M. Integrated analysis of methylation-driven genes and pretreatment prognostic factors in patients with hepatocellular carcinoma. BMC Cancer 2021;21:599. [PMID: 34034705 DOI: 10.1186/s12885-021-08314-5] [Reference Citation Analysis]
115 Zhao H, Zhu P, Han T, Ye Q, Xu C, Wu L, Liu F, Yin W, Li Z, Guo Y. Clinical characteristics analysis of 1180 patients with hepatocellular carcinoma secondary to hepatitis B, hepatitis C and alcoholic liver disease. J Clin Lab Anal 2020;34:e23075. [PMID: 31659795 DOI: 10.1002/jcla.23075] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
116 Wu Q, Liu TY, Hu BC, Li X, Wu YT, Sun XT, Jiang XW, Wang S, Qin XC, Ding HW, Zhao QC. CK-3, A Novel Methsulfonyl Pyridine Derivative, Suppresses Hepatocellular Carcinoma Proliferation and Invasion by Blocking the PI3K/AKT/mTOR and MAPK/ERK Pathways. Front Oncol 2021;11:717626. [PMID: 34395292 DOI: 10.3389/fonc.2021.717626] [Reference Citation Analysis]
117 Lim LJ, Ling LH, Neo YP, Chung AYF, Goh BKP, Chow PKH, Chan CY, Cheow PC, Lee SY, Lim TKH, Chong SS, Ooi LLPJ, Lee CG. Highly deregulated lncRNA LOC is associated with overall worse prognosis in Hepatocellular Carcinoma patients. J Cancer 2021;12:3098-113. [PMID: 33976720 DOI: 10.7150/jca.56340] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
118 Nakano M, Kuromatsu R, Niizeki T, Okamura S, Iwamoto H, Shimose S, Shirono T, Noda Y, Kamachi N, Koga H, Torimura T; Kurume Liver Cancer Study Group of Japan. Primary Treatment with Molecular-Targeted Agents for Hepatocellular Carcinoma: A Propensity Score-matching Analysis. Hepatol Commun 2020;4:1218-28. [PMID: 32766480 DOI: 10.1002/hep4.1535] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
119 Wang B, Yang S, Zhao W. Long Non-Coding RNA NRAD1 and LINC00152 are Highly Expressed and Associated with Prognosis in Patients with Hepatocellular Carcinoma. Onco Targets Ther 2020;13:10409-16. [PMID: 33116620 DOI: 10.2147/OTT.S251231] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
120 Guo Y, Chai B, Jia J, Yang M, Li Y, Zhang R, Wang S, Xu J. KLF7/VPS35 axis contributes to hepatocellular carcinoma progression through CCDC85C-activated β-catenin pathway. Cell Biosci 2021;11:73. [PMID: 33858520 DOI: 10.1186/s13578-021-00585-6] [Reference Citation Analysis]
121 Wei F, Yang L, Jiang D, Pan M, Tang G, Huang M, Zhang J. Long noncoding RNA DUXAP8 contributes to the progression of hepatocellular carcinoma via regulating miR-422a/PDK2 axis. Cancer Med 2020;9:2480-90. [PMID: 32022476 DOI: 10.1002/cam4.2861] [Cited by in Crossref: 6] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
122 Vale N, Duarte D, Silva S, Correia AS, Costa B, Gouveia MJ, Ferreira A. Cell-penetrating peptides in oncologic pharmacotherapy: A review. Pharmacol Res 2020;162:105231. [PMID: 33027717 DOI: 10.1016/j.phrs.2020.105231] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
123 Falkson SR, Bhambhvani HP, Hayden Gephart M. Hepatocellular Carcinoma Brain Metastases: A Single-Institution Experience. World Neurosurgery 2020;140:e27-32. [DOI: 10.1016/j.wneu.2020.03.189] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
124 Feng Y, Hao F. Hansenia weberbaueriana (Fedde ex H.Wolff) Pimenov & Kljuykov Extract Suppresses Proliferation of HepG2 Cells via the PTEN-PI3K-AKT Pathway Uncovered by Integrating Network Pharmacology and Iin Vitro Experiments. Front Pharmacol 2021;12:620897. [PMID: 33967754 DOI: 10.3389/fphar.2021.620897] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
125 Zhai CT, Tian YC, Tang ZX, Shao LJ. RNA methyltransferase NSUN2 promotes growth of hepatocellular carcinoma cells by regulating fizzy-related-1 in vitro and in vivo. Kaohsiung J Med Sci 2021. [PMID: 34370374 DOI: 10.1002/kjm2.12430] [Reference Citation Analysis]
126 Son DJ, Hong JY, Kim KH, Jeong YH, Myung DS, Cho SB, Lee WS, Kang YJ, Kim JW, Joo YE. Liver abscess caused by Clostridium haemolyticum infection after transarterial chemoembolization for hepatocellular carcinoma: A case report. Medicine (Baltimore) 2018;97:e0688. [PMID: 29742715 DOI: 10.1097/MD.0000000000010688] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 2.3] [Reference Citation Analysis]
127 Dai M, Chen N, Li J, Tan L, Li X, Wen J, Lei L, Guo D. In vitro and in vivo anti-metastatic effect of the alkaliod matrine from Sophora flavecens on hepatocellular carcinoma and its mechanisms. Phytomedicine 2021;87:153580. [PMID: 34029939 DOI: 10.1016/j.phymed.2021.153580] [Reference Citation Analysis]
128 Zhao Y, Ye L, Yu Y. MicroRNA-126-5p suppresses cell proliferation, invasion and migration by targeting EGFR in liver cancer. Clin Res Hepatol Gastroenterol 2020;44:865-73. [PMID: 32409283 DOI: 10.1016/j.clinre.2020.03.025] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
129 Wang Q, Tang M, Zhang S. Comparison of radiofrequency ablation and surgical resection for hepatocellular carcinoma conforming to the Milan criteria: a meta-analysis. ANZ J Surg 2021;91:E432-8. [PMID: 33404115 DOI: 10.1111/ans.16560] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
130 Wang Y, Su GF, Huang ZX, Wang ZG, Zhou PJ, Fan JL, Wang YF. Cepharanthine hydrochloride induces mitophagy targeting GPR30 in hepatocellular carcinoma (HCC). Expert Opin Ther Targets 2020;24:389-402. [PMID: 32106726 DOI: 10.1080/14728222.2020.1737013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
131 Xu H, Wei W, Y M, Dong C. Efficacy and safety of Chinese patent medicine (Jinlong capsule) in the treatment of advanced hepatocellular carcinoma: a meta-analysis. Biosci Rep 2020;40:BSR20194019. [PMID: 31872855 DOI: 10.1042/BSR20194019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
132 Cao Y, Zhang F, Wang H, Bi C, Cui J, Liu F, Pan H. LncRNA MALAT1 mediates doxorubicin resistance of hepatocellular carcinoma by regulating miR-3129-5p/Nova1 axis. Mol Cell Biochem 2021;476:279-92. [PMID: 32965597 DOI: 10.1007/s11010-020-03904-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
133 Wang L, Zhan Y, Wu Z, Lin M, Jin X, Jiang L, Qiu Y. A novel multitarget kinase inhibitor BZG with potent anticancer activity in vitro and vivo enhances efficacy of sorafenib through PI3K pathways in hepatocellular carcinoma cells. Biomed Pharmacother 2020;125:110033. [PMID: 32187962 DOI: 10.1016/j.biopha.2020.110033] [Reference Citation Analysis]
134 Zhang Z, Wang S, Liu Y, Meng Z, Chen F. Low lncRNA ZNF385D‑AS2 expression and its prognostic significance in liver cancer. Oncol Rep 2019;42:1110-24. [PMID: 31322274 DOI: 10.3892/or.2019.7238] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
135 Chen Y, Song S, Zhang L, Zhang Y. Circular RNA hsa_circ_0091579 facilitates the Warburg effect and malignancy of hepatocellular carcinoma cells via the miR-624/H3F3B axis. Clin Transl Oncol 2021. [PMID: 33934291 DOI: 10.1007/s12094-021-02627-4] [Reference Citation Analysis]
136 Sun JF, Zhang D, Gao CJ, Zhang YW, Dai QS. Exosome-Mediated MiR-155 Transfer Contributes to Hepatocellular Carcinoma Cell Proliferation by Targeting PTEN. Med Sci Monit Basic Res 2019;25:218-28. [PMID: 31645540 DOI: 10.12659/MSMBR.918134] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 8.5] [Reference Citation Analysis]
137 Ma D, Wang J, Liu L, Chen M, Wang Z. Acteoside as a potential therapeutic option for primary hepatocellular carcinoma: a preclinical study. BMC Cancer 2020;20:936. [PMID: 32993568 DOI: 10.1186/s12885-020-07447-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
138 Avgeris M, Panoutsopoulou K, Papadimitriou MA, Scorilas A. Circulating exosomal miRNAs: clinical significance in human cancers. Expert Rev Mol Diagn 2019;19:979-95. [PMID: 31594418 DOI: 10.1080/14737159.2019.1673732] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
139 Gao C, Wen Y, Jiang F, Gu X, Zhu X. Circular RNA circ_0008274 upregulates granulin to promote the progression of hepatocellular carcinoma via sponging microRNA -140-3p. Bioengineered 2021;12:1890-901. [PMID: 34002672 DOI: 10.1080/21655979.2021.1926195] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
140 Bian Y, Guo D. Targeted Therapy for Hepatocellular Carcinoma: Co-Delivery of Sorafenib and Curcumin Using Lactosylated pH-Responsive Nanoparticles. Drug Des Devel Ther 2020;14:647-59. [PMID: 32109990 DOI: 10.2147/DDDT.S238955] [Cited by in Crossref: 15] [Cited by in F6Publishing: 6] [Article Influence: 15.0] [Reference Citation Analysis]
141 Chen W, Wei T, Chen Y, Yang L, Wu X. Downregulation of IRAK1 Prevents the Malignant Behavior of Hepatocellular Carcinoma Cells by Blocking Activation of the MAPKs/NLRP3/IL-1β Pathway. Onco Targets Ther 2020;13:12787-96. [PMID: 33363384 DOI: 10.2147/OTT.S260793] [Reference Citation Analysis]
142 Li SQ, Chen Q, Qin HX, Yu YQ, Weng J, Mo QR, Yin XF, Lin Y, Liao WJ. Long Intergenic Nonprotein Coding RNA 0152 Promotes Hepatocellular Carcinoma Progression by Regulating Phosphatidylinositol 3-Kinase/Akt/Mammalian Target of Rapamycin Signaling Pathway through miR-139/PIK3CA. Am J Pathol 2020;190:1095-107. [PMID: 31954697 DOI: 10.1016/j.ajpath.2019.11.010] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
143 Li X, Xu J, Gu X, Chen L, Wu Q, Li H, Bai H, Yang J, Qian J. Case Report: Antiangiogenic Therapy Plus Immune Checkpoint Inhibitors Combined With Intratumoral Cryoablation for Hepatocellular Carcinoma. Front Immunol 2021;12:740790. [PMID: 34733279 DOI: 10.3389/fimmu.2021.740790] [Reference Citation Analysis]
144 Song Y, Jin X, Liu Y, Wang S, Bian F, Zhao Q, Shi H, Gao Z. Long noncoding RNA ZFPM2-AS1 promotes the proliferation, migration, and invasion of hepatocellular carcinoma cells by regulating the miR-576-3p/HIF-1α axis. Anticancer Drugs 2021;32:812-21. [PMID: 34102651 DOI: 10.1097/CAD.0000000000001070] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
145 Liu P, Tang Q, Chen M, Chen W, Lu Y, Liu Z, He Z. Hepatocellular Senescence: Immunosurveillance and Future Senescence-Induced Therapy in Hepatocellular Carcinoma. Front Oncol 2020;10:589908. [PMID: 33330071 DOI: 10.3389/fonc.2020.589908] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
146 Wang H, Wang H, Cui W, Zhang Q, Li J, Zhang Q. Enhanced expression of miR-889 forecasts an unfavorable prognosis and facilitates cell progression in hepatocellular carcinoma. Diagn Pathol 2021;16:51. [PMID: 34116691 DOI: 10.1186/s13000-021-01111-5] [Reference Citation Analysis]
147 Huang X, Qiu Z, Li L, Chen B, Huang P. m6A regulator-mediated methylation modification patterns and tumor microenvironment infiltration characterization in hepatocellular carcinoma. Aging (Albany NY) 2021;13:20698-715. [PMID: 34461607 DOI: 10.18632/aging.203456] [Reference Citation Analysis]
148 Guo J, Wang S, Han Y, Jia Z, Wang R. Effects of transarterial chemoembolization on the immunological function of patients with hepatocellular carcinoma. Oncol Lett 2021;22:554. [PMID: 34084221 DOI: 10.3892/ol.2021.12815] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
149 Liu R, Kong W, Jiang Z, Zheng S, Yuan X, Ye L. ABL1 Is a Prognostic Marker and Associated with Immune Infiltration in Hepatocellular Carcinoma. J Oncol 2021;2021:1379706. [PMID: 34484330 DOI: 10.1155/2021/1379706] [Reference Citation Analysis]
150 Nandhini JT, Ezhilarasan D, Rajeshkumar S. An ecofriendly synthesized gold nanoparticles induces cytotoxicity via apoptosis in HepG2 cells. Environmental Toxicology 2021;36:24-32. [DOI: 10.1002/tox.23007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
151 Liu Y, Zhang X, Zhang J, Tan J, Li J, Song Z. Development and Validation of a Combined Ferroptosis and Immune Prognostic Classifier for Hepatocellular Carcinoma. Front Cell Dev Biol 2020;8:596679. [PMID: 33425905 DOI: 10.3389/fcell.2020.596679] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
152 Cui Z, Li Y, Gao Y, Kong L, Lin Y, Chen Y. Cancer-testis antigen lactate dehydrogenase C4 in hepatocellular carcinoma: a promising biomarker for early diagnosis, efficacy evaluation and prognosis prediction. Aging (Albany NY) 2020;12:19455-67. [PMID: 33035196 DOI: 10.18632/aging.103879] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
153 Han Y, An Y, Jia G, Wang X, He C, Ding Y, Tang Q. Theranostic micelles based on upconversion nanoparticles for dual-modality imaging and photodynamic therapy in hepatocellular carcinoma. Nanoscale 2018;10:6511-23. [DOI: 10.1039/c7nr09717d] [Cited by in Crossref: 43] [Cited by in F6Publishing: 16] [Article Influence: 14.3] [Reference Citation Analysis]
154 Xu R, Lin L, Zhang B, Wang J, Zhao F, Liu X, Li Y, Li Y. Identification of prognostic markers for hepatocellular carcinoma based on the epithelial-mesenchymal transition-related gene BIRC5. BMC Cancer 2021;21:687. [PMID: 34112092 DOI: 10.1186/s12885-021-08390-7] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
155 Wang H, Zhang Q, Cui W, Li W, Zhang J. Circ_0004018 suppresses cell proliferation and migration in hepatocellular carcinoma via miR-1197/PTEN/PI3K/AKT signaling pathway. Cell Cycle 2021;20:2125-36. [PMID: 34570663 DOI: 10.1080/15384101.2021.1962633] [Reference Citation Analysis]
156 Li Y, Xu X, Weng S, Yan C, Chen J, Ye R. CT Image-Based Texture Analysis to Predict Microvascular Invasion in Primary Hepatocellular Carcinoma. J Digit Imaging 2020;33:1365-75. [PMID: 32968880 DOI: 10.1007/s10278-020-00386-2] [Reference Citation Analysis]
157 Li J, Liu ZY, Yu HB, Xue Q, Qu XS. Effects of oxymatrine on the proliferation of human liver cancer Bel-7404 cells: A protocol of systematic review and meta-analysis. Medicine (Baltimore) 2020;99:e20181. [PMID: 32501970 DOI: 10.1097/MD.0000000000020181] [Reference Citation Analysis]
158 Zhang Z, Wang S, Yang F, Meng Z, Liu Y. LncRNA ROR1‑AS1 high expression and its prognostic significance in liver cancer. Oncol Rep 2020;43:55-74. [PMID: 31746401 DOI: 10.3892/or.2019.7398] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
159 Li J, Zhou J, Kai S, Wang C, Wang D, Jiang J. Functional and Clinical Characterization of Tumor-Infiltrating T Cell Subpopulations in Hepatocellular Carcinoma. Front Genet 2020;11:586415. [PMID: 33133170 DOI: 10.3389/fgene.2020.586415] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
160 Wang M, Tao H, Huang P. Clinical significance of LARGE1 in progression of liver cancer and the underlying mechanism. Gene 2021;779:145493. [PMID: 33588034 DOI: 10.1016/j.gene.2021.145493] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
161 Huang D, Wei Y, Zhu J, Wang F. Long non-coding RNA SNHG1 functions as a competitive endogenous RNA to regulate PDCD4 expression by sponging miR-195-5p in hepatocellular carcinoma. Gene 2019;714:143994. [DOI: 10.1016/j.gene.2019.143994] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 9.0] [Reference Citation Analysis]
162 Gheena S, Ezhilarasan D. Syringic acid triggers reactive oxygen species–mediated cytotoxicity in HepG2 cells. Hum Exp Toxicol 2019;38:694-702. [DOI: 10.1177/0960327119839173] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 10.0] [Reference Citation Analysis]